edetic acid has been researched along with imatinib mesylate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buchdunger, E; Heldin, CH; Ostman, A; Pietras, K; Reed, RK; Rubin, K; Sjöquist, M | 1 |
1 other study(ies) available for edetic acid and imatinib mesylate
Article | Year |
---|---|
Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors.
Topics: Animals; Antineoplastic Agents; Benzamides; Capillary Permeability; Colonic Neoplasms; Edetic Acid; Enzyme Inhibitors; Extracellular Matrix Proteins; Imatinib Mesylate; Microdialysis; Oligonucleotides; Phosphorylation; Piperazines; Proto-Oncogene Proteins; Pyrimidines; Rats; Receptor Protein-Tyrosine Kinases; Receptor, Platelet-Derived Growth Factor beta; Receptors, Platelet-Derived Growth Factor; Substrate Specificity; Vascular Endothelial Growth Factor Receptor-1 | 2001 |